Barely Significant
← all excerpts

Second generation drug-eluting stents: a review of the everolimus-eluting platform.

Clin Med Insights Cardiol · 2013 · PMC3733651 · PMID 23926441

Europe PMCDOI
1
hedged sentence
0.1100
closest p · 2.2× alpha
0.1100
boldest claim

The sentences

failed to reach statistical significanceP = 0.11not close (p > 0.1)
TLR was observed in 10.7% of CYPHERTM treated patients compared to 8.1% of the XIENCE VTM treated patients, but failed to reach statistical significance ( P = 0.11). 20 There was an observed decrease in definite stent thrombosis, 0.7% vs. 1.3% in favor of XIENCE VTM, but again it failed to reach statistical significance ( P = 0.25). 20 The safety and efficacy of the Promus ElementTM stent has been recently demonstrated in a selected clinical trial population. 18 The SCAAR registry is a real world experience of DES implants in Sweden from November 2009 to March 2011.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.